Israel’s PainReform (see here previously) has developed new improved anti-inflammatory properties for its PRF-110 pain relief treatment. These have then been successfully tested in a Phase 3 multi-site US trial of 443 patients undergoing bunionectomy surgery.

https://painreform.com/releases/painreform-announces-positive-safety-profile-for-prf-110-in-phase-3-bunionectomy-study/

https://painreform.com/releases/painreform-announces-development-and-successful-manufacturing-of-new-formulations-providing-anti-inflammatory-and-extended-analgesic-effects/